C. Sylvester-Hvid

发表

Definition of supertypes for HLA molecules using clustering of specificity matrices

O. Lund, S. Brunak, C. Lundegaard, 2004, Immunogenetics.

SARS CTL Vaccine Candidates — HLA Supertype, Genome‐Wide Scanning and Biochemical Validation

S Brunak, O. Lund, S. Brunak, 2004, Tissue antigens.

Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds

C. Sylvester-Hvid, S. Buus, T. Blicher, 2001, European journal of immunology.

Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction.

S L Lauemøller, C. Sylvester-Hvid, K. Lamberth, 2002, Tissue antigens.

Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach

Søren Brunak, Morten Nielsen, Ole Lund, 2004, Bioinform..

One-Pot, Mix-and-Read Peptide-MHC Tetramers

C. Sylvester-Hvid, K. Lamberth, S. Justesen, 2008, PloS one.

SARS CTL vaccine candidates; HLA supertype‐, genome‐wide scanning and biochemical validation

S. Brunak, M. Nielsen, O. Lund, 2004, Tissue antigens.

MHC Class I Epitope Binding Prediction Trained on Small Data Sets

Søren Brunak, Morten Nielsen, Ole Lund, 2004, ICARIS.

Purification of correctly oxidized MHC class I heavy‐chain molecules under denaturing conditions: A novel strategy exploiting disulfide assisted protein folding

C. Sylvester-Hvid, S. Buus, T. Blicher, 2003, Protein science : a publication of the Protein Society.

Inhibitors of Apoptosis as Targets for Spontaneous T‐cell Responses in Cancer Patients: Potential Universal Antigens in Therapeutic Vaccinations Against Cancer

C. Sylvester-Hvid, H. Thomadsen, M. Nielsen, 2004, Infection and Immunity.